Project description
Automated management of medication prescription, dispensation and distribution
Hospitals, pharmacies and long-term healthcare facilities can face challenges with medication management including accurate prescription, dispensation and distribution. They must ensure adequate but not excess stock, which can result in waste of unused medicines; moreover, errors along the supply chain can have an impact on patient safety. The Iceland-based SME Thula – Nordic Source Solutions has developed MØBIUS, a software solution integrating electronic prescriptions, automated dispensing robots and distribution systems. Compared to manual management, it enhances accuracy and data security while reducing time, cost and resource waste. The EU-funded MOBIUS project will enable the team to add functionalities and conduct a feasibility study of the market including barriers and ways to overcome them.
Objective
Thula is an award-winning IT company based in Iceland with the mission of providing first class e-health solutions for medication management, logistics and electronic exchange of healthcare information. Thula has developed MØBIUS, a unique software solution that can manage the entire medication flow of hospital pharmacies, long-term healthcare facilities or companies providing healthcare services and logistics. Pharmaceuticals account for 20% of overall healthcare expenditures in OECD countries but a significant fraction of this investment could be reduced by eliminating inefficiencies in drug management (e.g. errors in prescription and dispensation; waste of unused medicines). MØBIUS is an integration platform designed to transform medicine management through enhanced automation. By linking different systems in the medication- and logistics loops, MØBIUS dramatically reduces inefficiencies in stock management and increases patient safety and security. MØBIUS integrates Electronic Prescriptions, automated dispensing robots and distribution systems. It also ensures availability of sufficient drugs for the patient, processes drug dispensing effectively, removes time wasting, saves resources, allows easy access to medicine, brings on more security on the data compared to manual-based systems, and improves accountability and traceability. The objectives of the SME Inst project include finalizing and validating the development of MØBIUS by integrating and packaging advanced features; search of commercial partners in target EU countries; in-depth assessment of entry strategy into the EU healthcare market; and a realistic and implementable business plan. We expect MØBIUS will generate about 40 new jobs and a cumulative ROI of €5.95 in the first 4 years after commercialization in Q1 2021. This submission, an improvement of a previous call in which we achieved a Seal of Excellence (13.22) intends to further demonstrate MØBIUS’ approach and our company’s value proposition.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences health care services eHealth
- natural sciences computer and information sciences software
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- social sciences sociology industrial relations automation
- social sciences economics and business business and management
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
600 AKUREYRI
Iceland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.